Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis?

Harwood CA Dr, Westgate K Ms, Gunstone S Ms, Brage S Dr, Wareham NJ Professor, McDermott CJ Dr, Shaw PJ Professor.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):377-384. Epub 2016 Mar 21.

2.

Toward precision medicine in amyotrophic lateral sclerosis.

Zou ZY, Liu CY, Che CH, Huang HP.

Ann Transl Med. 2016 Jan;4(2):27. doi: 10.3978/j.issn.2305-5839.2016.01.16. Review.

3.

Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Oskarsson B, Horton DK, Mitsumoto H.

Neurol Clin. 2015 Nov;33(4):877-88. doi: 10.1016/j.ncl.2015.07.009. Review.

PMID:
26515627
4.

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort.

Weisskopf MG, Cudkowicz ME, Johnson N.

Epidemiology. 2015 Nov;26(6):831-8. doi: 10.1097/EDE.0000000000000376.

5.

Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011.

Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE.

Am J Epidemiol. 2015 Sep 15;182(6):512-9. doi: 10.1093/aje/kwv095. Epub 2015 Jun 3.

6.
7.

Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.

Fondell E, O'Reilly ÉI, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, Gapstur SM, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):366-71. doi: 10.3109/21678421.2015.1020813. Epub 2015 Mar 30.

PMID:
25822002
8.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.

Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N.

Lancet Neurol. 2014 Nov;13(11):1108-13. doi: 10.1016/S1474-4422(14)70219-4. Epub 2014 Oct 7.

9.

Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme.

Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, Paraf F, Méjean A, Ploux O, Leleu JP, Brient L, Lengronne M, Pichon V, Combès A, El Abdellaoui S, Bonneterre V, Lagrange E, Besson G, Bicout DJ, Boutonnat J, Camu W, Pageot N, Juntas-Morales R, Rigau V, Masseret E, Abadie E, Preux PM, Marin B.

BMJ Open. 2014 Sep 1;4(8):e005528. doi: 10.1136/bmjopen-2014-005528.

10.

Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.

Stoyanov A, Pamphlett R.

PLoS One. 2014 Jul 24;9(7):e103572. doi: 10.1371/journal.pone.0103572. eCollection 2014.

11.

Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Fitzgerald KC, O'Reilly ÉJ, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

JAMA Neurol. 2014 Sep;71(9):1102-10. doi: 10.1001/jamaneurol.2014.1214.

12.

Dietary fiber and amyotrophic lateral sclerosis: results from 5 large cohort studies.

Fondell E, O'Reilly EJ, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, McCullough ML, Ascherio A.

Am J Epidemiol. 2014 Jun 15;179(12):1442-9. doi: 10.1093/aje/kwu089. Epub 2014 May 9.

13.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

14.
15.

Early-onset alopecia and amyotrophic lateral sclerosis: a cohort study.

Fondell E, Fitzgerald KC, Falcone GJ, O'Reilly EJ, Ascherio A.

Am J Epidemiol. 2013 Oct 1;178(7):1146-9. doi: 10.1093/aje/kwt096. Epub 2013 Aug 13.

16.

Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.

Trojsi F, Monsurrò MR, Tedeschi G.

Int J Mol Sci. 2013 Jul 24;14(8):15286-311. doi: 10.3390/ijms140815286. Review.

17.

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H.

Free Radic Biol Med. 2013 Dec;65:509-27. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21. Review.

18.

Magnesium intake and risk of amyotrophic lateral sclerosis: results from five large cohort studies.

Fondell E, O'Reilly EJ, Fitzgerald KC, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):356-61. doi: 10.3109/21678421.2013.803577. Epub 2013 Jun 18.

19.

Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.

Michal Freedman D, Kuncl RW, Weinstein SJ, Malila N, Virtamo J, Albanes D.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):246-51. doi: 10.3109/21678421.2012.745570. Epub 2013 Jan 4.

20.

Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.

Blechingberg J, Luo Y, Bolund L, Damgaard CK, Nielsen AL.

PLoS One. 2012;7(9):e46251. doi: 10.1371/journal.pone.0046251. Epub 2012 Sep 25.

Items per page

Supplemental Content

Write to the Help Desk